Cargando…
Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin–Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity
Tripterygium glycosides tablets (TGT) are widely used for treating nephrotic syndrome (NS), but hepatotoxicity is frequently reported. The presence of underlying disease(s) can alter the disposition of drugs and affect their efficacy and toxicity. However, no studies have reported the impact of NS o...
Autores principales: | Wu, Wei, Cheng, Rui, Boucetta, Hamza, Xu, Lei, Pan, Jing–ru, Song, Min, Lu, Yu–ting, Hang, Tai–jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221999/ https://www.ncbi.nlm.nih.gov/pubmed/35754482 http://dx.doi.org/10.3389/fphar.2022.910923 |
Ejemplares similares
-
Pharmacovigilance of Herb-Drug Interactions: A Pharmacokinetic Study on the Combined Administration of Tripterygium Glycosides Tablets and Leflunomide Tablets in Rats by LC-MS/MS
por: Boucetta, Hamza, et al.
Publicado: (2022) -
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021) -
Pharmacokinetics-Based Chronoefficacy of Semen Strychni and Tripterygium Glycoside Tablet Against Rheumatoid Arthritis
por: Lin, Jingpan, et al.
Publicado: (2021) -
Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
por: Zheng, Bidan, et al.
Publicado: (2023) -
Wells Syndrome Successfully Treated with Tripterygium Glycosides
por: Lu, Jiejie, et al.
Publicado: (2021)